Skip to main content
Journal for Immunotherapy of Cancer logoLink to Journal for Immunotherapy of Cancer
. 2020 Jun 23;8(1):e000676corr1. doi: 10.1136/jitc-2020-000676corr1

Correction: Inhibition of TGF-β-receptor signaling augments the antitumor function of ROR1-specific CAR T-cells against triple-negative breast cancer

PMCID: PMC7316411  PMID: 32581047

Stüber T, Monjezi R, Wallstabe L, et al. Inhibition of TGF-β-receptor signaling augments the antitumor function of ROR1-specific CAR T-cells against triple-negative breast cancer. J Immunother Cancer 2020;8:e000676. doi: 10.1136/jitc-2020-000676

Since the online publication of this article, the article has been updated to include the statement 'JW and MH contributed equally'.


Articles from Journal for Immunotherapy of Cancer are provided here courtesy of BMJ Publishing Group

RESOURCES